Other series of studies also showed the beneficial effects of genetically disrupting and pharmacologically inhibiting PARP-1 in cerebral ischemia, oxidative and nitrosative stress in islet cells, myocardial post-ischemic injury, and cerebral artery occlusion and its effect on motor function [39–47]. This evidence concerns the gene PARP1 and Cerebral ischemia.